Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Pharmacoeconomics and the medicinal chemist.

ABSTRACT: Pharmacoeconomics is a rational, scientific approach to compare the value (in terms of both cost and patient outcome) of one medication or drug therapy regimen to another. The impact of this new approach on both the practicing medicinal chemist and broader drug discovery efforts is considered.

SUBMITTER: Lindsley CW

PROVIDER: S-EPMC4190625 | biostudies-other | 2014 Oct

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Similar Datasets

Medicinal Plants in Commerce

Project description:Genetic reference data for use in botanical product identity testing

| PRJNA515225 | ENA

Fermentation of medicinal plants

Project description:Succession of bacterial and fungal communities during fermentation of medicinal plants

| PRJEB51209 | ENA

Medicinal brandy.

Project description:This paper describes the use of brandy and other forms of alcohol in the latter part of the 19th and early 20th centuries. Its prime use was as a cardiac stimulant as it seemed to increase the cardiac output and blood pressure. However it was also recognised as a depressant and was used as a sedative. Reconciling these two actions caused difficulties. In addition it was used as a food for invalids.

| S-EPMC3117141 | biostudies-literature

Prescribing medicinal cannabis.

Project description:The Australian Federal Government legalised access to medicinal cannabis in 2016: More than 100 different cannabis products are now available to prescribe Most are oral preparations oils or capsules containing delta-9-tetrahydrocannabinol or cannabidiol Dried-flower products are also available: As most products are unregistered drugs prescribing requires approval under the Therapeutic Goods Administration Special Access Scheme-B or Authorised Prescriber Scheme: Special Access Scheme Category B applications can be made online with approval usually being given within 24–48 hours However supply chain problems may delay dispensing by the pharmacy: By the end of 2019 over 28000 prescribing approvals had been issued to patients involving more than 1400 doctors mostly GPs More than 70000 approvals are projected by the end of 2020: Most prescriptions are for chronic non-cancer pain anxiety cancer-related symptoms epilepsy and other neurological disorders However the evidence supporting some indications is limited: Many doctors are cautious about prescribing cannabis While serious adverse events are rare there are legitimate concerns around driving cognitive impairment and drug dependence with products containing delta-9-tetrahydrocannabinol Cannabidiol-only products pose fewer risks:

| S-EPMC7572192 | biostudies-literature

Epigenetic Medicinal Chemistry.

Project description:The past decade has seen tremendous growth in our understanding of epigenetics and chromatin remodeling. Small, organic molecule modulators of a number of chromatin modifying proteins (CMPs) have been reported over this time frame and several of these have advanced to human clinical trials. In this Viewpoint, I summarize the current state of medicinal chemistry efforts focused on epigenetic targets and attempt to provide some insight into future directions on which the community may wish to focus.

| S-EPMC4753546 | biostudies-literature

Cullen corylifolium isolate:Medicinal plant

Project description:Cullen corylifolium isolate:Medicinal plant Clone ends

| PRJNA523104 | ENA

Medicinal plant microbiomes during fermentation

Project description:Deciphering the microbiome shift during fermentation of medicinal plants

| PRJEB15322 | ENA

Medicinal chemistry of cannabinoids.

Project description:The endocannabinoid system comprises the two well characterized Gi/o -protein coupled receptors (cannabinoid receptor 1 (CB1) and CB2), their endogenous lipid ligands, and the enzymes involved in their biosynthesis and biotransformation. Drug discovery efforts relating to the endocannabinoid system have been focused mainly on the two cannabinoid receptors and the two endocannabinoid deactivating enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MGL). This review provides an overview of cannabinergic agents used in drug research and those being explored clinically.

| S-EPMC4918805 | biostudies-literature

Medicinal chemistry for 2020.

Project description:Rapid advances in our collective understanding of biomolecular structure and, in concert, of biochemical systems, coupled with developments in computational methods, have massively impacted the field of medicinal chemistry over the past two decades, with even greater changes appearing on the horizon. In this perspective, we endeavor to profile some of the most prominent determinants of change and speculate as to further evolution that may consequently occur during the next decade. The five main angles to be addressed are: protein-protein interactions; peptides and peptidomimetics; molecular diversity and pharmacological space; molecular pharmacodynamics (significance, potential and challenges); and early-stage clinical efficacy and safety. We then consider, in light of these, the future of medicinal chemistry and the educational preparation that will be required for future medicinal chemists.

| S-EPMC3230884 | biostudies-literature

Foldamers in Medicinal Chemistry

Project description: Not available

| S-EPMC7271180 | biostudies-literature